These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mitochondrial Targeting of the Enteropathogenic Escherichia coli Map Triggers Calcium Mobilization, ADAM10-MAP Kinase Signaling, and Host Cell Apoptosis. Ramachandran RP; Spiegel C; Keren Y; Danieli T; Melamed-Book N; Pal RR; Zlotkin-Rivkin E; Rosenshine I; Aroeti B mBio; 2020 Sep; 11(5):. PubMed ID: 32934081 [TBL] [Abstract][Full Text] [Related]
4. The enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunction. Dean P; Scott JA; Knox AA; Quitard S; Watkins NJ; Kenny B PLoS Pathog; 2010 Jun; 6(6):e1000961. PubMed ID: 20585567 [TBL] [Abstract][Full Text] [Related]
5. E. coli secreted protein F promotes EPEC invasion of intestinal epithelial cells via an SNX9-dependent mechanism. Weflen AW; Alto NM; Viswanathan VK; Hecht G Cell Microbiol; 2010 Jul; 12(7):919-29. PubMed ID: 20088948 [TBL] [Abstract][Full Text] [Related]
6. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation. Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G mBio; 2012; 3(5):. PubMed ID: 23033475 [TBL] [Abstract][Full Text] [Related]
7. The EspF effector, a bacterial pathogen's Swiss army knife. Holmes A; Mühlen S; Roe AJ; Dean P Infect Immun; 2010 Nov; 78(11):4445-53. PubMed ID: 20679436 [TBL] [Abstract][Full Text] [Related]
8. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF. Nagai T; Abe A; Sasakawa C J Biol Chem; 2005 Jan; 280(4):2998-3011. PubMed ID: 15533930 [TBL] [Abstract][Full Text] [Related]
9. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis. Viswanathan VK; Weflen A; Koutsouris A; Roxas JL; Hecht G Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1165-70. PubMed ID: 18356531 [TBL] [Abstract][Full Text] [Related]
17. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection. Serapio-Palacios A; Finlay BB Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947 [TBL] [Abstract][Full Text] [Related]
18. Potential role of Escherichia coli DNA mismatch repair proteins in colon cancer. Khan S Crit Rev Oncol Hematol; 2015 Dec; 96(3):475-82. PubMed ID: 26014615 [TBL] [Abstract][Full Text] [Related]
19. Tight junctions and enteropathogenic E. coli. Weflen AW; Alto NM; Hecht GA Ann N Y Acad Sci; 2009 May; 1165():169-74. PubMed ID: 19538303 [TBL] [Abstract][Full Text] [Related]
20. EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability. Peralta-Ramírez J; Hernandez JM; Manning-Cela R; Luna-Muñoz J; Garcia-Tovar C; Nougayréde JP; Oswald E; Navarro-Garcia F Infect Immun; 2008 Sep; 76(9):3854-68. PubMed ID: 18559425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]